Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progressive supranuclear palsy.

R C Duvoisin1, L I Golbe, F E Lepore

  • 1Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick 08903.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|August 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review: neuropathology of acute phase encephalitis lethargica: a review of cases from the epidemic period.

Neuropathology and applied neurobiology·2009
Same author

Effects of visual pathway lesions on the visual aura of migraine.

Cephalalgia : an international journal of headache·2009
Same author

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.

Neurology·2008
Same author

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study.

Neurology·2006
Same author

BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study.

Neurology·2005
Same author

Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study.

Movement disorders : official journal of the Movement Disorder Society·2005

Progressive supranuclear palsy (PSP) is a parkinsonian disorder characterized by rigidity, dementia, and eye movement issues. Its exact cause is unknown, and current treatments are only palliative.

Area of Science:

  • Neuroscience
  • Neurology

Background:

  • Progressive supranuclear palsy (PSP) is a distinct neurological disorder.
  • It presents with extrapyramidal rigidity, bradykinesia, gait impairment, bulbar palsy, dementia, and supranuclear ophthalmoplegia.
  • PSP is a significant cause of parkinsonism.

Purpose of the Study:

  • To review the clinical features, etiology, and pathological findings of Progressive Supranuclear Palsy.
  • To highlight recent advancements in understanding PSP's neurobiology and imaging.

Main Methods:

  • Review of clinical observations and case studies.
  • Neuropsychological assessments.
  • Neuroimaging studies including CT, MRI, and PET scans.
  • Postmortem neuropathological examinations.

Related Experiment Videos

Main Results:

  • PSP is characterized by a specific set of motor and cognitive deficits.
  • Neuroimaging reveals characteristic patterns of brain atrophy, particularly in the midbrain and frontal lobes.
  • PET scans indicate frontal hypometabolism and dopaminergic receptor loss.
  • Postmortem studies confirm involvement of both dopaminergic and cholinergic systems.

Conclusions:

  • The etiology of PSP remains elusive.
  • While dementia is often mild, frontal lobe dysfunction is a key feature.
  • Current treatment options for PSP are limited and primarily palliative.